Abatacept Biosimilar, Endotoxin 0.05 EU/mg
$1,200.00 – $2,400.00
Abatacept Biosimilar, Endotoxin 0.05 EU/mg. Orencia biosimilar CHO stable cell line is available for licensing to manufacture the abatacept biosimilar protein.The research grade abatacept biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls and recombinant hIgG1 Fc proteins are available.
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | C007P.05 |
|---|---|
| Product Name | Abatacept Biosimilar, Endotoxin 0.05 EU/mg |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | Orencia, CTLA-4 Fc Fusion Protein |
| Summary | Recombinant protein composed of the extracellular domain of CTLA-4 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1). |
| Source/Host | The abatacept biosimilar protein was produced in the Orencia biosimilar CHO stable cell line. |
| Specificity/Sensitivity | The abatacept biosimilar protein specifically binds to the human CD80 (B7-1) with more avidity than to CD86 (B7-2). |
| Form Of Antibody | 0.2 uM filtered solution, pH 6.8 to 7.4, no stabilizers or preservatives. |
| Endotoxin | < 0.05 EU per 1 mg of the protein by the LAL method. |
| Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
| Shipping | The abatacept biosimilar protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | Orencia biosimilar CHO stable cell line is available for licensing to manufacture the abatacept biosimilar protein.The research grade abatacept biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls and recombinant hIgG1 Fc proteins are available. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C007P.05: Abatacept Biosimilar, Endotoxin 0.05 EU/mg
Recombinant protein composed of the extracellular domain of CTLA-4 fused with the Fc region of human immunoglobulin gamma 1 (hIgG1).
Abatacept (trade name Orencia, Bristol-Myers-Squibb), a fusion protein of a Fc fragment (human IgG1 isotype) and the extracellular domain of CTLA-4, can be used to extend graft survival while limiting the toxicity generated by standard immune suppressing regimens, such as calcineurin inhibitors. Abatacept binds to CD80 (B7-1) with more avidity than to CD86 (B7-2). Abatacept inhibits the costimulation of T cells. Abatacept differs from belatacept (trade name Nulojix) by only 2 amino acids.
The CTLA-4 protein is important for T-cell costimulation and selectively blocks the process of T-cell activation.
Syd Labs also provides the following CTLA-4 Fc Fusion Protein biosimilar:
Belatacept Biosimilar
Syd Labs provides the following research grade anti-CTLA-4 antibody biosimilars:
Ipilimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody
Tremelimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody
Please remember our product information: Abatacept Biosimilar, Endotoxin 0.05 EU/mg: C007P.05 Syd Labs
Additional information
| Ship from Country | USA |
|---|---|
| Size | 20 mg, 5 mg |